论文部分内容阅读
目的探讨雾化吸入布地奈德及沙丁胺醇治疗慢性阻塞性肺病急性发作期(acute exacerbationof chronic obstructive pulmonary disease,AECOPD)的临床疗效。方法选择80例确诊为AECOPD的病人,并随机分为治疗组(40例)和对照组(40例)。治疗组在常规抗感染、止咳化痰等综合性治疗的基础上,加用生理盐水加布地奈德混悬液和沙丁胺醇原液雾化吸入治疗,2次/d;对照组在常规抗感染、止咳化痰等综合性治疗的基础上,加用生理盐水加沙丁胺醇原液雾化吸入治疗,2次/d,7 d后观察两组肺功能及临床症状相关指标的改善情况。结果治疗组肺功能改善情况优于对照组(P<0.05或P<0.01),疗效优于对照组(P<0.05)。结论雾化吸入布地奈德和沙丁胺醇治疗AECOPD较单用沙丁胺醇疗效好,对临床治疗具有指导意义。
Objective To investigate the clinical efficacy of inhaled budesonide and albuterol in the treatment of acute exacerbation of chronic obstructive pulmonary disease (AECOPD). Methods 80 patients diagnosed as AECOPD were selected and randomly divided into treatment group (40 cases) and control group (40 cases). On the basis of general anti-infective and cough-phlegm-phlegm treatment, the treatment group was treated with inhalation of saline and budesonide suspension and salbutamol inhalation for 2 times / d. In the control group, Phlegm and other comprehensive treatment based on the addition of saline plus salbutamol inhalation of aerosol treatment, 2 times / d, 7 d after the observation of lung function and clinical symptoms related indicators of improvement. Results The improvement of lung function in the treatment group was better than that in the control group (P <0.05 or P <0.01), and the effect was better than that in the control group (P <0.05). Conclusion Inhaled budesonide and albuterol in the treatment of AECOPD than salbutamol alone is effective and has clinical significance.